Art is Her Best Friend

Yvonne is living her dream. She is an artist, dedicated to raising awareness and funds for vision research.

Meet Molly Burke, FFB Youth Ambassador

Youth Ambassador

Molly Burke is a youth ambassador for the FFB, educating the public about living with blindness while delivering a message of hope to those living with vision impairment.

Meet Norma Bastidas, mom on a mission

Mom on a Mission

Norma is the second person in history to run 7 of the planet's most unforgiving environments on 7 continents in 1 year in support of vision research. Read her about incredible journey.

Meet Dale Turner, proof that research does work

Miracles do happen

Dale Turner is the first Canadian to receive an experimental treatment and have some sight restored by gene therapy. Dale is proof that investing in research works.

Resources

Research Fact Sheets

These research fact sheets each provide an overview of a significant areas of vision research today including stem cell research, genetic therapies and other retina-protecting therapies. Each fact sheet is reviewed by one or more Canadian experts.

Genetic Testing Resources

Molecular genetic tests are clinical tests to determine the underlying genetic cause of a person's inherited vision loss. This section offers more information about the purpose and process of genetic testing.

Patient Registry

The FFB Patient Registry is a tool to help connect people living with retinal degerative eye diseases to scientists studying these conditions. Through the registry you can choose to make your records available for scientific research, and you can be notified if clinicial trials relevant to you are looking for participants.

Vision Quest Presentations

Vision Quest is a unique series of patient conferences to help people living with retinal degenerative diseases and their families learn more about the latest research. See a webcast of our Toronto 2011 conference along with audio recordings of 2011 meetings in Halifax and Vancouver.

Clinical Trials

A brief listing of Canadian clinical trials for retinal degnerative disorders.

Privacy Policy